nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.127	0.174	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.127	0.174	CbGbCtD
Dextropropoxyphene—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0914	0.126	CbGbCtD
Dextropropoxyphene—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0637	0.0876	CbGbCtD
Dextropropoxyphene—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0582	0.08	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0582	0.08	CbGbCtD
Dextropropoxyphene—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0399	0.0548	CbGbCtD
Dextropropoxyphene—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0384	0.0529	CbGbCtD
Dextropropoxyphene—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0371	0.0509	CbGbCtD
Dextropropoxyphene—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0273	0.0375	CbGbCtD
Dextropropoxyphene—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.017	0.0234	CbGbCtD
Dextropropoxyphene—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0167	0.023	CbGbCtD
Dextropropoxyphene—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0156	0.0214	CbGbCtD
Dextropropoxyphene—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0106	0.0146	CbGbCtD
Dextropropoxyphene—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000604	0.00223	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.000603	0.00223	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000599	0.00221	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000599	0.00221	CcSEcCtD
Dextropropoxyphene—Constipation—Topotecan—peripheral nervous system neoplasm	0.000598	0.00221	CcSEcCtD
Dextropropoxyphene—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.000597	0.0022	CcSEcCtD
Dextropropoxyphene—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000594	0.00219	CcSEcCtD
Dextropropoxyphene—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000594	0.00219	CcSEcCtD
Dextropropoxyphene—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000592	0.00219	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000591	0.00218	CcSEcCtD
Dextropropoxyphene—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00059	0.00218	CcSEcCtD
Dextropropoxyphene—Coma—Epirubicin—peripheral nervous system neoplasm	0.000589	0.00218	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000585	0.00216	CcSEcCtD
Dextropropoxyphene—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000585	0.00216	CcSEcCtD
Dextropropoxyphene—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000578	0.00213	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000577	0.00213	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000572	0.00211	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000572	0.00211	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000572	0.00211	CcSEcCtD
Dextropropoxyphene—Agitation—Vincristine—peripheral nervous system neoplasm	0.000571	0.00211	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00057	0.0021	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000569	0.0021	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000568	0.0021	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000568	0.0021	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000566	0.00209	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000564	0.00208	CcSEcCtD
Dextropropoxyphene—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000558	0.00206	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000553	0.00204	CcSEcCtD
Dextropropoxyphene—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000549	0.00203	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000549	0.00203	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000549	0.00203	CcSEcCtD
Dextropropoxyphene—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000545	0.00201	CcSEcCtD
Dextropropoxyphene—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000542	0.002	CcSEcCtD
Dextropropoxyphene—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00054	0.00199	CcSEcCtD
Dextropropoxyphene—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000538	0.00199	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000536	0.00198	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000536	0.00198	CcSEcCtD
Dextropropoxyphene—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.00196	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000522	0.00193	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000521	0.00192	CcSEcCtD
Dextropropoxyphene—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000518	0.00191	CcSEcCtD
Dextropropoxyphene—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000518	0.00191	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000516	0.00191	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000516	0.0019	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000515	0.0019	CcSEcCtD
Dextropropoxyphene—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000513	0.00189	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000511	0.00189	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000511	0.00189	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000505	0.00186	CcSEcCtD
Dextropropoxyphene—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000502	0.00185	CcSEcCtD
Dextropropoxyphene—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000498	0.00184	CcSEcCtD
Dextropropoxyphene—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000498	0.00184	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000497	0.00183	CcSEcCtD
Dextropropoxyphene—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000496	0.00183	CcSEcCtD
Dextropropoxyphene—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000492	0.00181	CcSEcCtD
Dextropropoxyphene—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000492	0.00181	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000479	0.00177	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.000478	0.00176	CcSEcCtD
Dextropropoxyphene—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000476	0.00176	CcSEcCtD
Dextropropoxyphene—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000476	0.00176	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000475	0.00175	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000475	0.00175	CcSEcCtD
Dextropropoxyphene—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000474	0.00175	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000469	0.00173	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000469	0.00173	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000468	0.00173	CcSEcCtD
Dextropropoxyphene—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00173	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000467	0.00173	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000464	0.00171	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000463	0.00171	CcSEcCtD
Dextropropoxyphene—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000463	0.00171	CcSEcCtD
Dextropropoxyphene—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000462	0.00171	CcSEcCtD
Dextropropoxyphene—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000459	0.00169	CcSEcCtD
Dextropropoxyphene—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000459	0.00169	CcSEcCtD
Dextropropoxyphene—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000458	0.00169	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.00168	CcSEcCtD
Dextropropoxyphene—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00045	0.00166	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000448	0.00166	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000445	0.00164	CcSEcCtD
Dextropropoxyphene—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000445	0.00164	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000442	0.00163	CcSEcCtD
Dextropropoxyphene—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000441	0.00163	CcSEcCtD
Dextropropoxyphene—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000441	0.00163	CcSEcCtD
Dextropropoxyphene—Rash—Topotecan—peripheral nervous system neoplasm	0.000441	0.00163	CcSEcCtD
Dextropropoxyphene—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000441	0.00163	CcSEcCtD
Dextropropoxyphene—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00044	0.00163	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00044	0.00162	CcSEcCtD
Dextropropoxyphene—Headache—Topotecan—peripheral nervous system neoplasm	0.000438	0.00162	CcSEcCtD
Dextropropoxyphene—Rash—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00162	CcSEcCtD
Dextropropoxyphene—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00162	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000438	0.00162	CcSEcCtD
Dextropropoxyphene—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000437	0.00161	CcSEcCtD
Dextropropoxyphene—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000437	0.00161	CcSEcCtD
Dextropropoxyphene—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000437	0.00161	CcSEcCtD
Dextropropoxyphene—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000436	0.00161	CcSEcCtD
Dextropropoxyphene—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000436	0.00161	CcSEcCtD
Dextropropoxyphene—Headache—Tretinoin—peripheral nervous system neoplasm	0.000435	0.00161	CcSEcCtD
Dextropropoxyphene—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000435	0.00161	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000433	0.0016	CcSEcCtD
Dextropropoxyphene—Constipation—Vincristine—peripheral nervous system neoplasm	0.000433	0.0016	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.0016	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000432	0.0016	CcSEcCtD
Dextropropoxyphene—Rash—Melphalan—peripheral nervous system neoplasm	0.000432	0.00159	CcSEcCtD
Dextropropoxyphene—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000432	0.00159	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00043	0.00159	CcSEcCtD
Dextropropoxyphene—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000423	0.00156	CcSEcCtD
Dextropropoxyphene—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000419	0.00155	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000418	0.00154	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000416	0.00153	CcSEcCtD
Dextropropoxyphene—Nausea—Topotecan—peripheral nervous system neoplasm	0.000416	0.00153	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000414	0.00153	CcSEcCtD
Dextropropoxyphene—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000414	0.00153	CcSEcCtD
Dextropropoxyphene—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000412	0.00152	CcSEcCtD
Dextropropoxyphene—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000412	0.00152	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000412	0.00152	CcSEcCtD
Dextropropoxyphene—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000407	0.0015	CcSEcCtD
Dextropropoxyphene—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000407	0.0015	CcSEcCtD
Dextropropoxyphene—Nausea—Melphalan—peripheral nervous system neoplasm	0.000407	0.0015	CcSEcCtD
Dextropropoxyphene—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000401	0.00148	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000401	0.00148	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.0004	0.00148	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.0004	0.00147	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000388	0.00143	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000388	0.00143	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00143	CcSEcCtD
Dextropropoxyphene—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000384	0.00142	CcSEcCtD
Dextropropoxyphene—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000377	0.00139	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000373	0.00138	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000369	0.00136	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000366	0.00135	CcSEcCtD
Dextropropoxyphene—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000365	0.00135	CcSEcCtD
Dextropropoxyphene—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000364	0.00134	CcSEcCtD
Dextropropoxyphene—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00133	CcSEcCtD
Dextropropoxyphene—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000361	0.00133	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00036	0.00133	CcSEcCtD
Dextropropoxyphene—Toremifene—ABCB1—peripheral nervous system neoplasm	0.000359	0.214	CrCbGaD
Dextropropoxyphene—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000358	0.00132	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000354	0.00131	CcSEcCtD
Dextropropoxyphene—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000352	0.0013	CcSEcCtD
Dextropropoxyphene—Constipation—Etoposide—peripheral nervous system neoplasm	0.000351	0.0013	CcSEcCtD
Dextropropoxyphene—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000348	0.00128	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000347	0.00128	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000341	0.00126	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000338	0.00125	CcSEcCtD
Dextropropoxyphene—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000337	0.00124	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000336	0.00124	CcSEcCtD
Dextropropoxyphene—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000335	0.00124	CcSEcCtD
Dextropropoxyphene—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000334	0.00123	CcSEcCtD
Dextropropoxyphene—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.00123	CcSEcCtD
Dextropropoxyphene—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00122	CcSEcCtD
Dextropropoxyphene—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000331	0.00122	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00033	0.00122	CcSEcCtD
Dextropropoxyphene—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00033	0.00122	CcSEcCtD
Dextropropoxyphene—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00033	0.00122	CcSEcCtD
Dextropropoxyphene—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000325	0.0012	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000325	0.0012	CcSEcCtD
Dextropropoxyphene—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000322	0.00119	CcSEcCtD
Dextropropoxyphene—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000322	0.00119	CcSEcCtD
Dextropropoxyphene—Rash—Vincristine—peripheral nervous system neoplasm	0.00032	0.00118	CcSEcCtD
Dextropropoxyphene—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000319	0.00118	CcSEcCtD
Dextropropoxyphene—Headache—Vincristine—peripheral nervous system neoplasm	0.000318	0.00117	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.00117	CcSEcCtD
Dextropropoxyphene—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00115	CcSEcCtD
Dextropropoxyphene—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000312	0.00115	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000307	0.00113	CcSEcCtD
Dextropropoxyphene—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.00113	CcSEcCtD
Dextropropoxyphene—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000303	0.00112	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000303	0.00112	CcSEcCtD
Dextropropoxyphene—Nausea—Vincristine—peripheral nervous system neoplasm	0.000301	0.00111	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000301	0.00111	CcSEcCtD
Dextropropoxyphene—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000295	0.00109	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000293	0.00108	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00108	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000289	0.00107	CcSEcCtD
Dextropropoxyphene—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.00107	CcSEcCtD
Dextropropoxyphene—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000285	0.00105	CcSEcCtD
Dextropropoxyphene—Rash—Cisplatin—peripheral nervous system neoplasm	0.000283	0.00104	CcSEcCtD
Dextropropoxyphene—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00104	CcSEcCtD
Dextropropoxyphene—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000282	0.00104	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000281	0.00104	CcSEcCtD
Dextropropoxyphene—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00103	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.00103	CcSEcCtD
Dextropropoxyphene—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000272	0.001	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000999	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000997	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000268	0.000988	CcSEcCtD
Dextropropoxyphene—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000266	0.000983	CcSEcCtD
Dextropropoxyphene—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000981	CcSEcCtD
Dextropropoxyphene—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000261	0.000964	CcSEcCtD
Dextropropoxyphene—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000963	CcSEcCtD
Dextropropoxyphene—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000957	CcSEcCtD
Dextropropoxyphene—Rash—Etoposide—peripheral nervous system neoplasm	0.000259	0.000956	CcSEcCtD
Dextropropoxyphene—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000259	0.000955	CcSEcCtD
Dextropropoxyphene—Headache—Etoposide—peripheral nervous system neoplasm	0.000257	0.000949	CcSEcCtD
Dextropropoxyphene—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000934	CcSEcCtD
Dextropropoxyphene—Propafenone—ABCB1—peripheral nervous system neoplasm	0.000253	0.151	CrCbGaD
Dextropropoxyphene—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000915	CcSEcCtD
Dextropropoxyphene—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000908	CcSEcCtD
Dextropropoxyphene—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000244	0.000902	CcSEcCtD
Dextropropoxyphene—Nausea—Etoposide—peripheral nervous system neoplasm	0.000244	0.0009	CcSEcCtD
Dextropropoxyphene—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000885	CcSEcCtD
Dextropropoxyphene—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000876	CcSEcCtD
Dextropropoxyphene—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000864	CcSEcCtD
Dextropropoxyphene—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000857	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000847	CcSEcCtD
Dextropropoxyphene—Shock—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000836	CcSEcCtD
Dextropropoxyphene—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000835	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000833	CcSEcCtD
Dextropropoxyphene—Bepridil—ABCB1—peripheral nervous system neoplasm	0.000225	0.134	CrCbGaD
Dextropropoxyphene—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000829	CcSEcCtD
Dextropropoxyphene—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.00081	CcSEcCtD
Dextropropoxyphene—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000794	CcSEcCtD
Dextropropoxyphene—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000793	CcSEcCtD
Dextropropoxyphene—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00021	0.000773	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000771	CcSEcCtD
Dextropropoxyphene—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000768	CcSEcCtD
Dextropropoxyphene—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000767	CcSEcCtD
Dextropropoxyphene—Fentanyl—ABCB1—peripheral nervous system neoplasm	0.000207	0.123	CrCbGaD
Dextropropoxyphene—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000757	CcSEcCtD
Dextropropoxyphene—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000205	0.000755	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000748	CcSEcCtD
Dextropropoxyphene—Loperamide—ABCB1—peripheral nervous system neoplasm	0.0002	0.119	CrCbGaD
Dextropropoxyphene—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000735	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000733	CcSEcCtD
Dextropropoxyphene—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000197	0.000727	CcSEcCtD
Dextropropoxyphene—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000711	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000701	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00019	0.0007	CcSEcCtD
Dextropropoxyphene—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000699	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000695	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000692	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000679	CcSEcCtD
Dextropropoxyphene—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000672	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000672	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000648	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000643	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000626	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000621	CcSEcCtD
Dextropropoxyphene—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00061	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000581	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000579	CcSEcCtD
Dextropropoxyphene—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000564	CcSEcCtD
Dextropropoxyphene—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000562	CcSEcCtD
Dextropropoxyphene—Trimipramine—ABCB1—peripheral nervous system neoplasm	0.00015	0.0893	CrCbGaD
Dextropropoxyphene—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000146	0.00054	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000538	CcSEcCtD
Dextropropoxyphene—Rash—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000536	CcSEcCtD
Dextropropoxyphene—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000535	CcSEcCtD
Dextropropoxyphene—Headache—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000532	CcSEcCtD
Dextropropoxyphene—Tamoxifen—ABCB1—peripheral nervous system neoplasm	0.000143	0.0854	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—peripheral nervous system neoplasm	0.000142	0.0846	CrCbGaD
Dextropropoxyphene—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00052	CcSEcCtD
Dextropropoxyphene—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000505	CcSEcCtD
Dextropropoxyphene—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.0005	CcSEcCtD
Dextropropoxyphene—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000496	CcSEcCtD
Dextropropoxyphene—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000495	CcSEcCtD
Dextropropoxyphene—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000492	CcSEcCtD
Dextropropoxyphene—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000467	CcSEcCtD
